BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33031216
Number of visits today
4369
Number of downloads
16219873
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Fenner BJ, Tan TE, Barathi AV, Tun SBB, Yeo SW, Tsai ASH, Lee SY, Cheung CMG, Chan CM, Mehta JS, Teo KYC. Gene-Based Therapeutics for Inherited Retinal Diseases. Front Genet 2021;12:794805. [PMID: 35069693 DOI: 10.3389/fgene.2021.794805] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 John MC, Quinn J, Hu ML, Cehajic-Kapetanovic J, Xue K. Gene-agnostic therapeutic approaches for inherited retinal degenerations. Front Mol Neurosci 2022;15:1068185. [PMID: 36710928 DOI: 10.3389/fnmol.2022.1068185] [Reference Citation Analysis]
2 Kumar S, Fry LE, Wang JH, Martin KR, Hewitt AW, Chen FK, Liu GS. RNA-targeting strategies as a platform for ocular gene therapy. Prog Retin Eye Res 2023;92:101110. [PMID: 35840489 DOI: 10.1016/j.preteyeres.2022.101110] [Reference Citation Analysis]
3 Maurizi E, Martella DA, Schiroli D, Merra A, Mustfa SA, Pellegrini G, Macaluso C, Chiappini C. Nanoneedles Induce Targeted siRNA Silencing of p16 in the Human Corneal Endothelium. Adv Sci (Weinh) 2022;:e2203257. [PMID: 36253148 DOI: 10.1002/advs.202203257] [Reference Citation Analysis]
4 Sharif NA. Electrical, Electromagnetic, Ultrasound Wave Therapies, and Electronic Implants for Neuronal Rejuvenation, Neuroprotection, Axonal Regeneration, and IOP Reduction. J Ocul Pharmacol Ther 2022. [PMID: 36126293 DOI: 10.1089/jop.2022.0046] [Reference Citation Analysis]
5 Maurizi E, Martella DA, Schiroli D, Merra A, Mustfa SA, Pellegrini G, Macaluso C, Chiappini C. Nanoneedles for targeted siRNA silencing of p16 in the Human Corneal Endothelium.. [DOI: 10.1101/2022.05.27.493597] [Reference Citation Analysis]
6 Bitoque DB, Fernandes CF, Oliveira AML, Silva GA. Strategies to Improve the Targeting of Retinal Cells by Non-Viral Gene Therapy Vectors. Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.899260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345